Search / 42249 results found

from
to

WEDNESDAY, Feb. 1, 2023 (HealthDay News) -- For patients with newly diagnosed multiple myeloma after induction treatment and autologous stem cell transplantation, maintenance therapy with carfilzomib, lenalidomide, and dexamethasone may be better than lenalidomide alone, according to a study published online Jan. 12 in The Lancet Oncology.